About CRU Hungary Kft.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
5
Celgene
3
Amgen
2
Hoffmann-La Roche
2
Incyte Corporation
1
Institut de Recherches Internationales Servier
1
Ironwood Pharmaceuticals, Inc.
1
Janssen Research & Development, LLC
1
Synta Pharmaceuticals Corp.
1
Clinical Trials at CRU Hungary Kft.
During the past decade, CRU Hungary Kft. conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 9 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 7 clinical trials were completed. i.e. 350%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
2013-04-01
2015-12-01
Terminated
696
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
2015-09-30
2016-11-25
Completed
309
Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis
2016-09-01
2018-12-17
Completed
694
Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma
2014-03-01
2018-10-22
Completed
65
A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment
2017-07-19
2019-02-25
Terminated
242
A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06)
2018-01-09
2020-10-16
Completed
233
Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors
2017-10-19
2023-01-04
Completed
226
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CRU Hungary Kft." #1 sponsor was "Pfizer" with 5 trials, followed by "Celgene" with 3 trials
sponsored, "Amgen" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Incyte Corporation"
with 2 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CRU Hungary Kft."
#1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at CRU Hungary Kft.
According to Clinical.Site data, the most researched conditions in "CRU Hungary Kft." are
"Crohn Disease" (3 trials), "Atopic Dermatitis" (2 trials), "Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors" (1 trials), "B-Cell Non-Hodgkin Lymphoma (NHL)" (1 trials) and "Chronic Kidney Disease (CKD)" (1 trials). Many other conditions were trialed in "CRU Hungary Kft." in a lesser frequency.
Clinical Trials Intervention Types at CRU Hungary Kft.
Most popular intervention types in "CRU Hungary Kft." are "Drug" (16 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Ozanimod" (3 trials), "Avelumab Phase 1b" (1 trials), "Avelumab Phase 2" (1 trials) and "CP-690,550" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CRU Hungary Kft.
The vast majority of trials in "CRU Hungary Kft." are
17 trials for "All" genders.
Clinical Trials Status at CRU Hungary Kft.
Currently, there are NaN active trials in "CRU Hungary Kft.".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in CRU Hungary Kft.,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in CRU Hungary Kft., 2 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".